Literature DB >> 16094583

Subjective outcomes following sural nerve harvest.

Michael Miloro1, Julie A Stoner.   

Abstract

PURPOSE: The goal of this study was to assess subjective patient recovery of donor site sensory deficit following sural nerve harvest for trigeminal nerve repair surgery. PATIENTS AND METHODS: A review of 42 consecutive sural nerve graft patient records yielded 26 patients, at least 20 months following sural nerve grafting for trigeminal nerve repair, who participated in a telephone questionnaire survey to assess subjective outcomes. The association between donor site outcome and other factors, including nerve graft recovery, age, gender, pain, cold sensitivity, scar cosmesis and tactile sensitivity, and legal involvement were analyzed, and presurgical and present levels of donor and nerve graft site sensibility were compared.
RESULTS: The perceived area of donor site sensory deficit decreased significantly over time. Postoperative donor site pain and cold sensitivity at low levels were reported by few patients, and the majority have completely resolved. Most patients reported no problems with scar cosmesis or pain. There was a moderate agreement between donor site recovery and nerve graft recovery (kappa = 0.32). Few patients reported satisfaction with one site and not the other or complete dissatisfaction with both sites. Other factors such as age, gender, or legal involvement were not found to correlate with satisfaction level.
CONCLUSIONS: The use of a questionnaire for subjective assessment of neurosensory recovery following nerve graft repair yields outcomes information that is generally not considered in the traditional clinical patient assessment. The majority of patients tolerate sural nerve harvest without significant donor site morbidity.

Entities:  

Mesh:

Year:  2005        PMID: 16094583     DOI: 10.1016/j.joms.2005.04.031

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  8 in total

1.  Functional Organization of Cutaneous and Muscle Afferent Synapses onto Immature Spinal Lamina I Projection Neurons.

Authors:  Jie Li; Mark L Baccei
Journal:  J Neurosci       Date:  2017-01-09       Impact factor: 6.167

2.  Injury of Muscular but not Cutaneous Nerve Drives Acute Neuropathic Pain in Rats.

Authors:  Jie Zhu; Zhiyong Chen; Yehong Fang; Wanru Duan; Yikuan Xie; Chao Ma
Journal:  Neurosci Bull       Date:  2020-01-13       Impact factor: 5.203

3.  Reconstruction of sciatic nerve after traumatic injury in humans - factors influencing outcome as related to neurobiological knowledge from animal research.

Authors:  Amanda Maripuu; Anders Björkman; Isabella M Björkman-Burtscher; Peter Mannfolk; Gert Andersson; Lars B Dahlin
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2012-10-10

Review 4.  Chronic postoperative complications and donor site morbidity after sural nerve autograft harvest or biopsy.

Authors:  Ivica Ducic; Joshua Yoon; Gregory Buncke
Journal:  Microsurgery       Date:  2020-04-10       Impact factor: 2.425

5.  Long-Term Outcomes of Donor Site Morbidity After Sural Nerve Graft Harvesting.

Authors:  Kaoru Tada; Mika Nakada; Masashi Matsuta; Daisuke Yamauchi; Kazuo Ikeda; Hiroyuki Tsuchiya
Journal:  J Hand Surg Glob Online       Date:  2020-02-06

6.  Efficacy of low level laser therapy on neurosensory recovery after injury to the inferior alveolar nerve.

Authors:  Tuncer Ozen; Kaan Orhan; Ilker Gorur; Adnan Ozturk
Journal:  Head Face Med       Date:  2006-02-15       Impact factor: 2.151

7.  Subjective outcome related to donor site morbidity after sural nerve graft harvesting: a survey in 41 patients.

Authors:  Alexander Hallgren; Anders Björkman; Anette Chemnitz; Lars B Dahlin
Journal:  BMC Surg       Date:  2013-09-24       Impact factor: 2.102

8.  Treatment of Neuroma-induced Chronic Pain and Management of Nerve Defects with Processed Nerve Allografts.

Authors:  Ivica Ducic; Joshua Yoon; Kyle R Eberlin
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.